During Friday’s Morning trade, Shares of MAXIMUS, Inc. (NYSE:MMS), lost -0.58% to $53.29.
MAXIMUS, stated financial results for the three months and year ended September 30, 2015.
Highlights for the fourth quarter and full fiscal year 2015 comprise:
- Fourth quarter revenue growth of 33% to $578.7 million and GAAP diluted earnings per share of $0.53
- Fiscal year 2015 revenue growth of 23% to $2.1 billion, GAAP diluted earnings per share of $2.35 and adjusted diluted earnings per share of $2.39
- Cash and cash equivalents that totaled $74.7 million at September 30, 2015
- Record signed year-to-date contract awards of $3.4 billion, new contracts pending of $149.4 million, and a sales pipeline of $3.2 billion at September 30, 2015
- As formerly revealed in an 8-K filing on November 6, 2015, the Company is now reporting information for three segments. All historical segment data in this press release have been reclassified for comparison purposes.
For the fourth quarter of fiscal 2015, revenue raised 33% (38% on a constant currency basis) to $578.7 million, contrast to $435.4 million stated for the same period last year. The improvement in revenue was driven by organic growth and the acquisitions of Acentia and Remploy. This was offset by a 5% decline related to unfavorable foreign currency translation. For the fourth quarter of fiscal 2015, net income attributable to MAXIMUS totaled $35.4 million, or $0.53 per diluted share. This compares to diluted earnings per share of $0.53 for the fourth quarter of 2014.
Revenue for fiscal year 2015 raised 23% (27% on a constant currency basis) to $2.1 billion, contrast to $1.7 billion stated for fiscal 2014. The improvement in revenue was driven by organic growth primarily in the Health Services Segment and the U.S. Federal Services Segment, as well as revenue from the acquisitions of Acentia and Remploy. This was offset by a 4% decline from unfavorable foreign currency translation. For fiscal year 2015, net income attributable to MAXIMUS totaled $157.8 million, or $2.35 earnings per diluted share, which comprised about $0.04 per diluted share of acquisition-related expenses. Not Taking Into Account the acquisition-related expenses, adjusted diluted earnings per share for fiscal year 2015 were $2.39. This compares to GAAP diluted earnings per share of $2.11 for fiscal year 2014.
MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates through two segments, Health Services and Human Services.
Shares of Roka Bioscience Inc (NASDAQ:ROKA), declined -0.69% to $1.44, during its current trading session.
Roka Bioscience, stated its financial results for the quarter and nine months ended September 30, 2015.
Third Quarter 2015 Financial Results:
Revenue for the quarter ended September 30, 2015 was $1.5 million contrast with $1.5 million for the third quarter of 2014 and $1.5 million for the second quarter of 2015. As of September 30, 2015, the Company had 39 instruments placed with customers under commercial agreements contrast to 36 instruments as of September 30, 2014 and 41 instruments as of June 30, 2015.
Total operating expenses for the third quarter of 2015 were $9.6 million contrast with $9.9 million in the third quarter of 2014. Net loss for the third quarter of 2015 was $8.5 million, or $0.49 per share, contrast with a net loss of $9.1 million, or $0.64 per share, in the third quarter of 2014. In July 2014, upon completion of the Company’s IPO, all shares of Convertible Preferred Stock were converted into common stock at their respective conversion ratio. The calculation of net loss per share in 2014 preceding to the completion of the IPO excludes all potential Common shares issuable for Convertible Preferred Stock because the effect of counting them would have been anti-dilutive.
As of September 30, 2015, the Company had cash and cash equivalents and marketable securities of $37.9 million contrast with $57.1 million at December 31, 2014.
Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States.
Finally, Shares of Alon Blue Square Israel Ltd (NYSE:BSI), gained 8.79%, and is now trading at $0.359.
Alon Blue Square Israel Ltd., declared that it has been notified by the trustee for the Series C Debentures, following a meeting of the Series C Bondholders, it has postponed the record date for the forthcoming payment of principal and interest on the Series C Debentures (the “Payment”) from November 24, 2015 until November 26, 2015 and set the payment date for the Payment to December 8, 2015.
Alon Blue Square Israel Ltd. (hereinafter: “Alon Blue Square”) operates in five reportable operating segments and is the largest retail company in the State of Israel. In the Fueling and Commercial Sites segment, Alon Blue Square through its 63.13% partner, which is listed on the Tel Aviv stock exchange (“TASE”), Dor Alon Energy in Israel (1988) Ltd is one of the four largest fuel retail companies in Israel based on the number of petrol stations and a leader in the field of convenience stores operating a chain of 211 petrol stations and 220 convenience stores in different formats in Israel. In its supermarket segment, Alon Blue Square, as a pioneer in the modern food retail, through its 100% partner, Mega Retail Ltd., presently operates 150 supermarkets under different formats, each offering a wide range of food products, “Near Food” products and “Non-Food” products at varying levels of service and pricing. In its “Houseware and textile” segment, Alon Blue Square, through its TASE traded 77.51% partner, Na’aman Group (NV) Ltd. Operates specialist outlets in self-operation and franchises and offers a wide range of “Non-Food” products as retailer and wholesaler. In the Real Estate segment, Alon Blue Square, through its TASE traded 53.92% partner Blue Square Real Estate Ltd., owns, leases and develops income producing commercial properties and projects. In addition, Alon Blue Square operates the issuance and clearance of gift certificates, and through Diners Club Israel Ltd., an associate held at 36.75%, which operates in the sector of issuance and clearance of YOU credit cards to the customer club members of the group.
Alon Blue Square Israel Ltd. operates as a retail company in Israel. Its Fueling and Commercial Sites segment develops, constructs, and operates vehicle fueling stations, adjacent commercial centers, and independent convenience stores; markets fuel and other products through filling stations and convenience stores; and directly markets distillates to customers.